Genetic Technologies Acquires AffinityDNA Direct-to-Consumer Business

Genetic Technologies Acquires EasyDNA from BelHealth

July 19, 2021

Biotechnology

Genetic Technologies Limited (GENE/GTG) acquired the direct-to-consumer eCommerce business, brands and distribution rights of General Genetics Corporation trading as EasyDNA from BelHealth Investment Fund LP for US$4.0 million (cash, ADRs and escrow). The deal gives Genetic Technologies an established DTC genomics platform and distribution in ~40 countries (70+ websites) to accelerate its health & wellness and serious-disease test commercialisation and global expansion.

GeneDx to Acquire Fabric Genomics

May 7, 2025

Healthcare Services

GeneDx announced it would acquire Fabric Genomics, an AI-powered genomic interpretation platform company, to enable decentralized testing powered by centralized intelligence. The deal expands GeneDx’s capabilities in NICU genomic testing and genomic newborn screening and targets global delivery of genomic insights.

Dotmatics Acquires SoftGenetics to Expand Genetic Analysis Capabilities

June 12, 2023

Software

Dotmatics has acquired SoftGenetics, a bioinformatics software company that provides genetic analysis tools for research, clinical, and forensic applications. The acquisition expands Dotmatics' R&D scientific software portfolio by adding SoftGenetics' suite of sequencing and genotyping products while allowing SoftGenetics to operate as a standalone business within Dotmatics.

Eurobio Scientific Acquires GenDx (Genome Diagnostics B.V.)

October 4, 2022

Biotechnology

Paris-based Eurobio Scientific has acquired all outstanding shares of Dutch transplant diagnostics specialist GenDx (Genome Diagnostics B.V.), following a share purchase agreement signed on August 17. The acquisition expands Eurobio's molecular diagnostics portfolio in transplantation and secures the company legacy with proceeds funding a GenDx foundation established by the founders.

Twist Bioscience Acquires iGenomX

June 30, 2021

Biotechnology

Twist Bioscience acquired iGenomX, a developer of high-throughput multiplex NGS library preparation tools, to expand its NGS workflow capabilities and accelerate customer conversion from microarray genotyping to sequencing-based genotyping. The deal consideration was $35 million (combination of cash and Twist stock, plus up to $5 million contingent stock), and Twist expects modest near-term financial impact with incremental revenue from the acquired business in fiscal 2023.

AMP Agency Acquires Genome

May 24, 2022

Marketing & Advertising

AMP Agency, a full-service digital marketing agency and part of Advantage Solutions, has acquired Genome, an award-winning digital innovation and product development company. The acquisition strengthens AMP Agency's technology and product capabilities and supports its strategy to scale technology-enabled innovation and expand internationally; Genome's leadership will join AMP in senior technology roles.